?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
  • Biosimilars 101
  • Policies
    • Biosimilars are a Free-Market Solution
    • The Biosimilar Access and Affordability Act
  • News
  • Resources

News

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
July 28, 2022 signalgroup
Hillel Cohen Member Spotlight
News
July 21, 2022 signalgroup
The Biosimilars Forum Launches Updated Website Content
News
July 14, 2022 signalgroup
Rebecca Mandell Member Spotlight
News
June 22, 2022 signalgroup
The Biosimilars Forum Welcomes Legislation to Hold PBMs Accountable for Unfair Practices
News
June 21, 2022 signalgroup
Rachel Turow Member Spotlight
News
June 16, 2022 signalgroup
Brian Lehman Member Spotlight
News
June 7, 2022 signalgroup
The Biosimilars Forum Commends FTC for Probe into PBMs
News
June 6, 2022 signalgroup
Biosimilars Forum Welcomes Fresenius Kabi
News
April 6, 2022 signalgroup
Biosimilars Forum Letter to Senate HELP Committee on FDA User Fee Agreements
News
March 31, 2022 signalgroup
HHS Inspector General Report: Biosimilars Could Generate Significant Medicare Part D Savings
  • Prev page
  • 04
  • 05
  • 06
  • 07
  • 08
  • Next page

  • Biosimilars 101
  • Policies
  • Stay Connected
Biosimilars Forum
© 2026 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us